Filing Details
- Accession Number:
- 0001209191-20-057653
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-10 16:33:38
- Reporting Period:
- 2020-11-09
- Accepted Time:
- 2020-11-10 16:33:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1757898 | Steris Plc | STE | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1819129 | Julia Madsen | C/O 70 Sir Roger'S Quay Dublin L2 2 | Senior Vp, Life Sciences | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2020-11-09 | 1,100 | $45.34 | 5,741 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2020-11-09 | 800 | $53.52 | 6,541 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2020-11-09 | 1,100 | $192.36 | 5,441 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2020-11-09 | 800 | $192.55 | 4,641 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option (right to buy) | Acquisiton | 2020-11-09 | 1,100 | $0.00 | 1,100 | $45.34 |
| Ordinary Shares | Employee Stock Option (right to buy) | Acquisiton | 2020-11-09 | 800 | $0.00 | 800 | $53.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-05-31 | No | 4 | M | Direct | |
| 0 | 2024-05-30 | No | 4 | M | Direct |
Footnotes
- Price reflects a weighted average sale price for multiple transactions ranging from $192.0701 to $192.5460 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- 2,714 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 308 on June 1, 2021; 121 on June 1, 2021; 92 on June 1, 2021; 123 on June 1, 2021; 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 349 on October 2, 2023; 123 on June 1, 2023; 123 on June 3, 2024; and 349 on October 1, 2024.
- This option to purchase 1,100 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 1,100 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.
- This option to purchase 800 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 800 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.
Billionaire Hedge Funds
